Frankfurt - Delayed Quote EUR
Blueprint Medicines Corporation (2L9.F)
109.00
-1.00
(-0.91%)
At close: 2:52:48 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-145,552
-192,586
-436,847
-502,277
-298,653
Investing Cash Flow
-59,553
-47,501
274,040
-149,541
-225,860
Financing Cash Flow
215,340
273,111
119,225
561,810
50,716
End Cash Position
134,195
113,639
81,524
124,904
215,119
Income Tax Paid Supplemental Data
1,287
1,104
--
6,505
694
Interest Paid Supplemental Data
87,037
79,852
38,467
9,814
0
Capital Expenditure
-5,357
-4,630
-16,062
-8,919
-261,241
Issuance of Capital Stock
0
48,936
0
0
0
Issuance of Debt
--
146,973
97,933
137,786
0
Free Cash Flow
-150,909
-197,216
-452,909
-511,196
-559,894
12/31/2021 - 5/11/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
38I.F Intellia Therapeutics, Inc.
6.79
-9.44%
UP0.F Ultragenyx Pharmaceutical Inc.
33.40
+3.73%
4DN.MU Denali Therapeutics Inc.
12.91
-2.23%
26CA.F ImmunityBio, Inc.
2.6460
-3.18%
2LB.F Iovance Biotherapeutics, Inc.
1.9322
+1.19%
NEXI NexImmune, Inc.
0.0001
0.00%
LVTX LAVA Therapeutics N.V.
1.3100
0.00%
IKNA Ikena Oncology, Inc.
1.3500
-1.46%
ABOS Acumen Pharmaceuticals, Inc.
1.0700
-6.14%
PRTG Portage Biotech Inc.
5.99
-5.07%